Senior Learning Manager US Oncology Commercialization Learning at Bristol-Myers Squibb

Madison, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Oncology, BiotechnologyIndustries

Requirements

Bachelor’s degree or equivalent
Skills needed to ensure immediate and long-term success of training organization
Experience as a talented learning professional
Ability to work collaboratively in a fast-paced and complex matrix organization (e.g., with Oncology Commercialization Teams, WW Centre of Excellence, Enterprise Learning Services, Sales, Marketing, Sales Operations, Medical, Legal, Compliance)

Responsibilities

Accountable for product and disease training for the US Oncology Business Unit, including design, development, and execution of training assets for new hire training, brand updates, selling skills, new product/indication launches, competitive product launches, POA meetings, and Field Readiness Meetings
Evaluate ongoing Commercialization Learning needs and recommend appropriate strategies, tactics, and budget planning for assigned products
Collaborate with training colleagues, Sales, Operations, Marketing leadership, and preceptors to implement results-focused, performance-based, standardized training and development processes
Strategic planning and development of a comprehensive sales training curriculum for use during training classes, POAs, and other national/regional/district meetings
Coordinate and align across matrix and cross-functional teams to ensure all training materials meet goals and objectives of Sales and Marketing
Ensure training resources (e.g., materials, workshops, infographics/job aids) meet all regulatory, legal, and compliance requirements for assigned projects and initiatives
Deployment and delivery of a curriculum inclusive of key competencies: Selling Skills, Scientific Agility (clinical disease state knowledge, competitor and market landscapes), and Business Analytics
Work with and/or manage external vendors and internal personnel to ensure successful design and execution of assigned training programs and projects
Assess and analyze the effectiveness of assigned training programs and initiatives utilizing Kirkpatrick Model
Leverage the internal Learning Experience Platform (LXP) to design, develop, and deliver engaging adult learning experiences across eLearning, live, and virtual training modalities
Engage the WW Centre of Excellence to share/leverage assets

Skills

Learning Design

Training Development

Product Training

Disease Training

New Hire Training

Selling Skills

Launch Training

Field Readiness

Oncology Commercialization

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free